15 Followers on Owler

Genomas

develops DNA-guided drug for treatment of mental illness, pain, heart disease and diabetes... Read more
OverviewCompetitorsFundingNews & Insights

Genomas

develops DNA-guided drug for treatment of mental illness, pain, heart disease and diabetes... Read more
Genomas President & CEO: Gualberto Ruaño

President & CEO

Gualberto Ruaño

CEO Approval Rating

69/100

2004

PrivateSubsidiary of Rennova Health, Inc.

Pharmaceuticals & Biotechnology
Pharmaceuticals
2834 NAICS listing

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
100-250
Agree?
Funding
$500K

News

Nov 02, 2016
Reuters
Genomas: BRIEF-Rennova Health achieves corporate milestone with recent acquisition of Genomas

Genomas Competitors

1Esperion
2Cardialen
3Amarin
4Gemphire Therapeutics
5Amryt Pharma
6Regeneron
7Kardium
8The Medicines Company
9CardioFocus
10Sanofi
Unlock 25 + competitors

Trending Companies